Literature DB >> 25621803

Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption.

C M Wilk1, J C Fischer2, G Schieren3, J M Rox2, R Haas1, L C Rump3, G Kobbe1, T Schroeder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25621803     DOI： 10.1038/bmt.2014.321

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A.

Authors:  N Braun; C Faul; D Wernet; M Schnaidt; G Stuhler; L Kanz; T Risler; H Einsele
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

2.  A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

Authors:  U Gergis; S Mayer; B Gordon; T Mark; R Pearse; T Shore; K Van Besien
Journal:  Bone Marrow Transplant       Date:  2014-02-17       Impact factor: 5.483

3.  Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.

Authors:  Vanderson Rocha; Myriam Labopin; Annalisa Ruggeri; Marina Podestà; Andrea Gallamini; Francesca Bonifazi; Fermin M Sanchez-Guijo; Montserrat Rovira; Gerard Socie; Ioannis Baltadakis; Mauricette Michallet; Eric Deconinck; Andrea Bacigalupo; Mohamad Mohty; Eliane Gluckman; Francesco Frassoni
Journal:  Transplantation       Date:  2013-05-27       Impact factor: 4.939

Review 4.  Desensitization for solid organ and hematopoietic stem cell transplantation.

Authors:  Andrea A Zachary; Mary S Leffell
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988
  4 in total
  2 in total

1.  Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody.

Authors:  Ying-Jun Chang; Lan-Ping Xu; Yu Wang; Xiao-Hui Zhang; Huan Chen; Yu-Hong Chen; Feng-Rong Wang; Wei Han; Yu-Qian Sun; Chen-Hua Yan; Fei-Fei Tang; Ming-Rui Huo; Xiang-Yu Zhao; Xiao-Dong Mo; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Bone Marrow Transplant       Date:  2020-05-08       Impact factor: 5.483

2.  Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.

Authors:  Rongli Zhang; Yi He; Donglin Yang; Erlie Jiang; Qiaoling Ma; Aiming Pang; Weihua Zhai; Jialin Wei; Sizhou Feng; Mingzhe Han
Journal:  J Clin Lab Anal       Date:  2020-02-28       Impact factor: 2.352
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.